Hi Letitia
My sister is involved in a phase II clinical study of Lapatinib for breast cancer mets to the brain in Boston. Eric Winer at the Dana Farber Cancer Center is leading the study in the Boston area -- two other oncologists at Beth Israel Deaconess Medical Center and Massachusetts General Hospital (both also in Boston) are also participating with Dr. Winer. There is also a doctor in the Washington, DC area participating.
My understanding is that mets in the brain have to be progressing to be eligible for this study. When my sister was scanned 4 weeks post whole-brain-radiation, she was not yet eligible, because the MRI showed shrinkage to her 4 small brain lesions. A followup scan 6 weeks later showed further diminishment on 3 lesions, but a 4th had begun to grow again, which made her eligible for the Lapatinib. She will start her 8-week followup scans at the end of April.
We met another young woman who is doing well in the trial (12-16 weeks into it). My sister is tolerating the Lapatinib pills well after minor initial physical adjustment -- her headaches remain the same so far -- not better, not worse -- so it's hard to tell yet how well it's working for her.
Here's the link to the U.S. Nat'l Cancer Institute clinical trial:
http://www.nci.nih.gov/search/ViewClinical...earchid=1543565
Good luck and God bless you.
MA